BDBM703747 2-[[4-[3-fluoro-5- isobutyl-2-(2H- tetrazol-5-yl)phen- yl]-2,6-dimethyl- piperazin-1-yl]- methyl]-5-methyl- thiazole::US20240368133, Compound A-224
SMILES Cc4cnc(C(C)N3C(C)CN(c1cc(CC(C)C)cc(F)c1c2nn[nH]n2)CC3C)s4
InChI Key InChIKey=OWNUXBULJVZZKN-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 703747
TargetType-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor(Human)
Confo Therapeutics
US Patent
Confo Therapeutics
US Patent
Affinity DataIC50: 92.2nMAssay Description:All synthesized ligands were evaluated in a radioligand assay by displacing 125I-[Sar1, Ile8]-Angiotensin II (Perkin Elmer, NEX248050UC) from human A...More data for this Ligand-Target Pair
